Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Izumi, Raquel
345  Ergebnisse:
Personensuche X
?
1

Neutrophil elastase as a versatile cleavage enzyme for acti..:

Rebstock, Anne-Sophie ; Wiedmann, Mareike ; Stelte-Ludwig, Beatrix...
Frontiers in Pharmacology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Enitociclib, a Selective CDK9 Inhibitor, Induces Complete R..:

Frigault, Melanie M. ; Mithal, Arushi ; Wong, Harvey...
Cancer Research Communications.  3 (2023)  11 - p. 2268-2279 , 2023
Link: https://doi.org/10.1158/..
 
?
3

Discovery of VIP236, an αvβ3-Targeted Small-Molecule–Drug C..:

Lerchen, Hans-Georg ; Stelte-Ludwig, Beatrix ; Heroult, Melanie...
Cancers.  15 (2023)  17 - p. 4381 , 2023
Link: https://doi.org/10.3390/..
 
?
4

VIP152 is a selective CDK9 inhibitor with pre-clinical in v..:

Sher, Steven ; Whipp, Ethan ; Walker, Janek...
Leukemia.  37 (2022)  2 - p. 326-338 , 2022
Link: https://doi.org/10.1038/..
 
?
5

A Small Molecule–Drug Conjugate (SMDC) Consisting of a Modi..:

Lerchen, Hans-Georg ; Stelte-Ludwig, Beatrix ; Kopitz, Charlotte...
Cancers.  14 (2022)  2 - p. 391 , 2022
Link: https://doi.org/10.3390/..
 
?
6

Evaluation of the Pharmacokinetics and Safety of a Single D..:

Xu, Yan ; Izumi, Raquel ; Nguyen, Helen...
The Journal of Clinical Pharmacology.  62 (2022)  6 - p. 812-822 , 2022
Link: https://doi.org/10.1002/..
 
?
7

The highly selective Bruton tyrosine kinase inhibitor acala..:

Pinney, Jonathan J. ; Blick-Nitko, Sara K. ; Baran, Andrea M....
Haematologica.  107 (2022)  6 - p. 1460-1465 , 2022
Link: https://doi.org/10.3324/..
 
?
8

A phase 1/2 study of the combination of acalabrutinib and v..:

Collins, Graham P. ; Clevenger, Tracy N. ; Burke, Kathleen A....
Leukemia & Lymphoma.  62 (2021)  11 - p. 2625-2636 , 2021
Link: https://doi.org/10.1080/..
 
?
9

Pooled analysis of safety data from clinical trials evaluat..:

Furman, Richard R. ; Byrd, John C. ; Owen, Roger G....
Leukemia.  35 (2021)  11 - p. 3201-3211 , 2021
Link: https://doi.org/10.1038/..
 
?
10

Phase II study of acalabrutinib in ibrutinib-intolerant pat..:

Rogers, Kerry A. ; Thompson, Philip A. ; Allan, John N....
Haematologica.  106 (2021)  9 - p. 2364-2373 , 2021
Link: https://doi.org/10.3324/..
 
?
11

Changing for the Better: Discovery of the Highly Potent and..:

Lücking, Ulrich ; Kosemund, Dirk ; Böhnke, Niels...
Journal of Medicinal Chemistry.  64 (2021)  15 - p. 11651-11674 , 2021
Link: https://doi.org/10.1021/..
 
?
12

Acalabrutinib with or without obinutuzumab versus chlorambu..:

Sharman, Jeff P ; Egyed, Miklos ; Jurczak, Wojciech...
The Lancet.  395 (2020)  10232 - p. 1278-1291 , 2020
Link: https://doi.org/10.1016/..
 
?
13

A randomized phase 2 trial of pembrolizumab versus pembroli..:

Zhang, Tian ; Harrison, Michael R. ; O'Donnell, Peter H....
Cancer.  126 (2020)  20 - p. 4485-4497 , 2020
Link: https://doi.org/10.1002/..
 
?
14

Phase 2 Study of Acalabrutinib in Ibrutinib-Intolerant Pati..:

Rogers, Kerry A. ; Thompson, Philip A. ; Allan, John N....
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  - p. S282-S283 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Acalabrutinib with Obinutuzumab in Treatment-Naive (TN) and..:

Woyach, Jennifer A. ; Rogers, Kerry A. ; Bhat, Seema...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  - p. S281 , 2019
Link: https://doi.org/10.1016/..
 
1-15